Leading the Charge in Oncology: A Conversation with ASCO's Dr. Clifford Hudis

In this episode of Precision Signals, Sean Khozin, MD, MPH sits down with Clifford A. Hudis, MD, FACP, FASCO, CEO of the American Society of Clinical Oncology (ASCO), to trace a career that began with a childhood memory of Brian Piccolo and Memorial Sloan Kettering, and now sits at the helm of the world's largest professional society in cancer care.Dr. Hudis reflects on his path from Northeast Philadelphia to an accelerated BA/MD program, to a transformative fellowship at MSK under Larry Norton, and through three decades building the modern breast cancer clinic. He shares what it has meant to lead ASCO through a period of profound change: the rise of AI and real-world evidence, the persistence of access and equity gaps, the evolving science of clinical trials, and the tension between precision and pragmatism at the bedside.Takeaways:Dr. Clifford A. Hudis reflects on his transformative journey from a modest upbringing to becoming the CEO of ASCO, illustrating the profound impact of early life experiences on career trajectory.The evolution of oncology, particularly in breast cancer treatment, is marked by significant advancements such as dose-dense chemotherapy and HER2-targeted therapies, reshaping patient outcomes.ASCO's guidelines are undergoing a revolutionary change towards dynamic, living guidelines, ensuring that oncologists have access to the most current and relevant treatment protocols.AI is positioned to become an integral component of clinical practice, enhancing decision-making and patient care, thereby allowing oncologists to focus more on patient relationships.The tension between science and societal perceptions of healthcare necessitates an ongoing dialogue to build trust and understanding, particularly in the face of misinformation and skepticism.Leadership in oncology requires not only clinical excellence but also an embrace of business acumen and a visionary outlook, fostering progress in a rapidly changing medical landscape.Companies mentioned in this episode:ASCOAmerican Society of Clinical OncologyMemorial Sloan KetteringGenentechMD AndersonDana FarberNCCNNIHNCIAACRACS